Back

Notification report


Full notification file


General information

Notification Number
B/GB/19/DR/001/W

Member State to which the notification was sent
United Kingdom

Date of acknowledgement from the Member State Competent Authority
15/07/2019

Title of the Project
A Phase I, randomised, double-blind, placebo-controlled, parallel group dose escalation study to evaluate the safety, tolerability and immunogenicity of three doses of a potential oral enteric fever vaccine (ZH9 + ZH9PA) in healthy subjects 18 to 45 years of age.

Proposed period of release:
01/09/2019 to 30/09/2021

Name of the Institute(s) or Company(ies)
Prokarium Ltd., ;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
Bacterium

Identity of the GMO:
Genus: Salmonella
Species: enterica


Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
ZH9SalmonellaentericaentericaTy2Typhi

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known